Clinical Application of 18F-FDG-PET Quantification in Hematological Malignancies: Emphasizing Multiple Myeloma, Lymphoma and Chronic Lymphocytic Leukemia
MZ Zadeh - Clinical Lymphoma Myeloma and Leukemia, 2023 - Elsevier
Most hematological malignancies display heightened glycolytic activity, leading to their
detectability through 18 F-FDG-PET imaging. PET quantification enables the extraction of …
detectability through 18 F-FDG-PET imaging. PET quantification enables the extraction of …
Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status
D Wang, M Zhang, X Gao, L Yu - PLoS One, 2016 - journals.plos.org
The study objective was to retrospectively analyze the metabolic variables derived from 18 F-
fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography …
fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography …
[HTML][HTML] Relationships between DCE-MRI, DWI, and 18F-FDG PET/CT parameters with tumor grade and stage in patients with head and neck squamous cell …
HM Bülbül, O Bülbül, S Sarıoğlu… - Molecular Imaging …, 2021 - ncbi.nlm.nih.gov
Objectives: Properties of head and neck squamous cell carcinoma (HNSCC) such as
cellularity, vascularity, and glucose metabolism interact with each other. This study aimed to …
cellularity, vascularity, and glucose metabolism interact with each other. This study aimed to …
Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
C Stokke, JN Nørgaard, H Feiring Phillips… - Molecular Imaging and …, 2022 - Springer
Abstract Purpose [18F] FDG PET/CT in multiple myeloma (MM) is currently the best
technology to demonstrate patchy and extramedullary disease. However,[18F] FDG PET has …
technology to demonstrate patchy and extramedullary disease. However,[18F] FDG PET has …
Intensity of bone involvement: a quantitative 18F-FDG PET/CT evaluation for monitoring outcome of multiple myeloma
MES Takahashi, C Mosci, GO Duarte… - Nuclear medicine …, 2021 - journals.lww.com
Purpose The parameter intensity of bone involvement (IBI) was recently proposed to
quantitatively assess patients with multiple myeloma using 18 F-fluorodeoxyglucose-PET …
quantitatively assess patients with multiple myeloma using 18 F-fluorodeoxyglucose-PET …
Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value
J Li, H Tan, T Xu, H Shi, P Liu - Annals of Hematology, 2021 - Springer
Purpose To evaluate the prognostic value of bone marrow (BM) imaging pattern and other
imaging findings assessed by 18F-FDG PET-CT in multiple myeloma (MM) and to find out …
imaging findings assessed by 18F-FDG PET-CT in multiple myeloma (MM) and to find out …
Progress of modern imaging modalities in multiple myeloma
T Terao, K Matsue - International journal of hematology, 2022 - Springer
Multiple myeloma (MM) is an incurable hematological malignancy, but treatment advances
made in the last two decades have markedly improved its prognosis. Imaging has played a …
made in the last two decades have markedly improved its prognosis. Imaging has played a …
Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer
T Nobashi, S Koyasu, Y Nakamoto… - The British Journal of …, 2016 - academic.oup.com
Objective: To investigate the prognostic value of fluorine-18 fludeoxyglucose (FDG) positron
emission tomography (PET) parameters for small-cell lung cancer (SCLC), according to the …
emission tomography (PET) parameters for small-cell lung cancer (SCLC), according to the …
Prediction of pretreatment 18F-FDG-PET/CT parameters on the outcome of first-line therapy in patients with metastatic breast cancer
Y Li, C Liu, B Wang, X Hu, C Gong, Y Zhao… - … Journal of General …, 2021 - Taylor & Francis
Objective: 18F-fluorodeoxyglucose positron emission tomography/computed tomography
(18F-FDG-PET/CT) can provide prognostic information, especially 18F-FDG uptake has …
(18F-FDG-PET/CT) can provide prognostic information, especially 18F-FDG uptake has …
Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer Using 3′-Deoxy-3′-[18F]-Fluorothymidine …
F Iommelli, V De Rosa, S Gargiulo, M Panico… - Clinical Cancer …, 2014 - AACR
Purpose: MET amplification is one of the mechanisms underlying acquired resistance to
EGFR tyrosine kinase inhibitors (TKI) in non–small cell lung cancer (NSCLC). Here, we …
EGFR tyrosine kinase inhibitors (TKI) in non–small cell lung cancer (NSCLC). Here, we …